Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir.

Biochemistry
José C ClementeBen M Dunn

Abstract

A series of HIV-1 protease mutants has been designed in an effort to analyze the contribution to drug resistance provided by natural polymorphisms as well as therapy-selective (active and non-active site) mutations in the HIV-1 CRF_01 A/E (AE) protease when compared to that of the subtype B (B) protease. Kinetic analysis of these variants using chromogenic substrates showed differences in substrate specificity between pretherapy B and AE proteases. Inhibition analysis with ritonavir, indinavir, nelfinavir, amprenavir, saquinavir, lopinavir, and atazanavir revealed that the natural polymorphisms found in A/E can influence inhibitor resistance. It was also apparent that a high level of resistance in the A/E protease, as with B protease, is due to it aquiring a combination of active site and non-active site mutations. Structural analysis of atazanavir bound to a pretherapy B protease showed that the ability of atazanavir to maintain its binding affinity for variants containing some resistance mutations is due to its unique interactions with flap residues. This structure also explains why the I50L and I84V mutations are important in decreasing the binding affinity of atazanavir.

References

Jan 1, 1985·Cell·S Wain-HobsonM Alizon
Feb 1, 1995·Protein Engineering·A C WallaceJ M Thornton
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·D J KempfX P Kong
Dec 16, 1997·Journal of Medicinal Chemistry·S W KaldorJ H Tatlock
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Aug 3, 1999·European Journal of Biochemistry·B MahalingamI T Weber
Aug 14, 1999·The Journal of Biological Chemistry·D B OlsenL C Kuo
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·Y F GongP F Lin
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·A Velazquez-CampoyE Freire
Jan 16, 2002·Protein Science : a Publication of the Protein Society·Nancy M KingCelia A Schiffer
Jun 12, 2002·Bioorganic & Medicinal Chemistry·Vincent StollDaniel W Norbeck
Dec 2, 2004·Progress in Biophysics and Molecular Biology·Hiroyasu Ohtaka, Ernesto Freire
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jan 15, 2005·AIDS Research and Human Retroviruses·Sarawut NukoolkarnWichet Leelamanit

❮ Previous
Next ❯

Citations

Feb 17, 2009·Journal of Computer-aided Molecular Design·Xiaoqing LiuCe Hao
Feb 16, 2012·Journal of Chemical Information and Modeling·Hong KangZhiwei Cao
Sep 20, 2011·Chemical Reviews·Jeeyeon Lee, Nina M Goodey
Jan 15, 2009·Journal of the American Chemical Society·Luis GalianoGail E Fanucci
Oct 1, 2009·Journal of the American Chemical Society·Jamie L KearGail E Fanucci
Apr 30, 2009·AIDS Research and Human Retroviruses·Abraham Joseph KandathilGopalan Sridharan
Nov 1, 2006·Current Opinion in Infectious Diseases·Rami Kantor
Apr 3, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Roxana M ComanBen M Dunn
Sep 4, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Piyamat JinnopatMasanori Kameoka
Oct 23, 2015·Physical Chemistry Chemical Physics : PCCP·Zhanglong LiuGail E Fanucci
Feb 13, 2016·Frontiers in Microbiology·Masaaki NakashimaYasumasa Iwatani
Jan 25, 2011·Bioorganic & Medicinal Chemistry Letters·Andreas FlütschGreta R Patzke
May 20, 2009·Bioorganic & Medicinal Chemistry·Eriketi Z LoizidouLeondios G Kostrikis
Feb 25, 2010·Acta Crystallographica. Section D, Biological Crystallography·Arthur H RobbinsRobert McKenna
Sep 12, 2015·Journal of Medicinal Chemistry·Nicolas ChéronEugene I Shakhnovich
Apr 7, 2011·The Journal of Physical Chemistry. B·Michal KolárPavel Hobza
Dec 25, 2016·Journal of Structural and Functional Genomics·Clara Shionyu-MitsuyamaTsuyoshi Shirai
Jul 14, 2018·Chemical Biology & Drug Design·Siyabonga I MaphumuloHendrik G Kruger
Jun 22, 2007·Chemical Biology & Drug Design·Virginie LafontErnesto Freire
Aug 31, 2020·Biochemical and Biophysical Research Communications·Trang T TranGail E Fanucci
May 2, 2018·Journal of Chemical Theory and Computation·Benedict W J Irwin, David J Huggins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.